Directors
-
 Weaver H. Gaines 
- Chairman and Co-Founder
- Chairman since founding, and CEO from founding until 2003. From April to November 1992, he was a Senior
Advisor on the Washington campaign staff of Bush/Quayle 92. From
1985 to 1992, he held various senior executive positions with
The Mutual Life Insurance Company of New York and its operating
subsidiaries. He is also a director of Unified Financial Services,
Inc., an SEC-reporting company, AquaGene, Inc., and past Chairman
of the Board of BioFlorida, the Florida biotechnology trade association
-
-
- David C.
Peck
Chairman, Finance
Committee and Co-Founder
- Mr. David Peck is a co-founder of Ixion, a Director since March 1993, our
President from April 1994 to July 2000, and our Chief Financial Officer from
May 1995 to July 2000. Since October 1995, Mr. Peck has also been Chief
Executive Officer of BACOMPT, a printing company located in Carmel, Indiana.
Mr. Peck is the brother of Dr. Peck, our Senior Vice President and Chief
Scientist.
-
-
- Bengt Ågerup,
Ph.D.
Director
- Dr. Ågerup founded Q-Med AB (publ) of Uppsala, Sweden in 1987, and became
its Chairman in December 2000. From 1999 to 2000 he was Q-Med's Deputy
Chief Executive Officer and Vice President, Director of Research and
Development. From 1995 to 1999, he was the President of Q-Med. Q-Med is
traded on the Stockholm Stock Exchange; it is not related to Q-Med, Inc., a
Delaware company.
-
-
- Carina Bolin
Director
- Ms. Bolin is Head of the Legal Department of Q-Med AB (publ) since 2000. Prior to that, she was an intellectual property lawyer and partner of the firm Dr. Ludwig Brann in Stockholm and Uppsala. Previously she was a public prosecutor. She received her LLM from Uppsala University.
-
-
- Håkan Edstrom
Director
- Mr. Edstrom is President and Chief Operating Officer of MannKind Corporation. From 1998 to 2001, he held senior executive positions with Bausch & Lomb, including Senior Corporate Vice President, and President, Bausch & Lomb, Americas Region. Prior to that, he held a variety of executive positions with Pharmacia & Upjohn. He is a director of Gimbel Vision International, a public company and of Q-Med AB (publ). Q-Med is traded on the Stockholm Stock Exchange; it is not related to Q-Med, Inc. a Delaware company.
-
-
-
-
-
-
-
- Officers and Key Employees
 Harmeet Sidhu, Ph.D.
President and Chief Operating Officer
- Dr. Sidhu was elected President and COO in December 2002. Prior to that she was Vice President and Director of Research, Oxalate Division. From 1992 to May 1995, she was an Assistant Professor in the Biochemistry Department at the Postgraduate Institute of Medical Education and Research ("P.G.I.M.E.R.") in Chandigarh, India.
|
 Ammon B. Peck, Ph.D.
Senior Vice President, Chief Scientist, and Chairman of the Scientific Advisory Board, and Scientific Co-Founder
- Dr. Ammon Peck is the scientific co-founder of Ixion and has been its Senior Vice President and Chief Scientist and Chairman of the Scientific Advisory Board since April 1993. Dr. Peck has been at the University of Florida since 1979 and is presently Professor of Pathology and Laboratory Medicine at Florida's College of Medicine and former President of the medical faculty. Dr. Peck is Mr. Peck's brother.
|
 Clarence Lee, Ph.D.
Vice President, Business Development
- Dr. Lee joined Ixion in 2003. He comes to Ixion with almost twenty years of experience in the Medical Device and Biotech industry. Previously from 1999 he was the Director of New Business Assessment at CR Bard, Inc. He has received his M.S. and Ph.D. in Chemistry and Biochemistry from Lehigh University followed by post-doctoral work at Princeton.
|
 Albert Fosmoe II
VP Regulatory & Quality Assurance & Director of Operations, Oxalate Division
- Mr. Fosmoe joined Ixion in March 2002. He has 13 years of biotech experience. Previously he was Director of Quality Assurance and Regulatory Affairs at US BioMaterials Corporation. He holds BS and ACS degrees in chemistry from the University of Florida and is a member of the American Society for Quality Control and the Regulatory Affairs Professional Society.
|
 Tracy Deson
Accountant
- Ms. Deson joined Ixion in 2002. Previously, Ms. Deson worked for Infineer, Inc., a software and computer technology firm in Tarpon Springs. She has over 12 years professional experience with financial accounting and management, budgeting, and risk- management.
|
-
-
-
-
-
-
-
-
-
-
-
-
-
- Scientific Consultants
-
- Milton J. Allison, Ph.D.
- Dr. Allison has long been a pioneer in oxalate research, having discovered and named Oxalobacter formigenes. He is presently Professor of Microbiology, Immunology, and Preventive Medicine, Iowa State University and Microbiologist Emeritus of the National Animal Disease Center, USDA, Ames, Iowa. He earned his Ph.D. from the University of Maryland.
-
-
- Karl-E. Arfors, Ph.D.
- From 1993 to the present he has been President of Experimental Medicine, Inc., a company he founded. Previous experience includes various research positions with Pharmacia, AB, of Uppsala, Sweden, president and co-founder of the La Jolla Institute for Experimental Medicine, and executive director for biological sciences for the Liposome Company.
-
-
- Marguerite Hatch, Ph.D.
- Dr. Hatch is a Professor in Pediatrics/Nephrology Department at Northwestern University in Chicago. Previously she was a Professor at the College of Medicine, Nephrology Division, and Director of the Kidney Stone Center at the University of California, Irvine College of Medicine since 1990.Previously she was Director of the New York Kidney Stone Center, SUNY Health Science Center. She earned her B.Sc. with Honors from the University College, Dublin, Ireland and her Ph.D. in 1978 from Trinity College, Dublin, Ireland.
-
-
- Ross P. Holmes, Ph.D.
- Ross P. Holmes, Ph.D., is an associate professor of surgical sciences-urology at Wake Forest University School of Medicine. Dr. Holmes graduated with a bachelor's of science degree and PhD in biochemistry from Australian National University, Canberra. Before joining Wake Forest University, he was a senior food scientist and research associate in the department of Food Science at University of Illinois. Holmes has been published extensively on the topics of oxalate and hyperoxaluria.
-
-
- Saeed Khan, Ph.D.
- Dr. Khan is Associate Professor of Pathology at the University of Florida College of Medicine and a leader in the field of oxalate research and molecular/microscopy. His current and previous committee memberships include the NIH Ad hoc Reviewer on Urinary Stone Grants; member, Center for the Study of Lithiasis and Pathological Calcification; and member of the Shands Stone Center Committee. He earned his undergraduate degree from Agra University in Agra, India, his masters of science degree from the Peshawar University, Peshawar, Pakistan, and his Ph.D. from the University of Florida.
-
-
- Desmond Schatz, M.D.
- Dr. Schatz is the Medical Director of the Diabetes Center and Associate Professor of Pediatric Endocrinology at the University of Florida Medical School. He is a Diplomate of the American Board of Pediatric Endocrinology and a member of the American Diabetes Association, the International Diabetes Federation, and the Immunology of Diabetes Society. He received his undergraduate degree from St. David's College in Johannesburg, South Africa, and his medical degree from the University of the Witwatersrand Medical School in Johannesburg.
-
-
- Hans Wigzell, M.D., D.Sc
- Dr. Wigzell is presently the Rector of Stockholm's famed Karolinska Institute. He received his medical degree and doctorate of science from Karolinska. From 1982 onwards, he has been Chairman of the Department of Immunology at Karolinska. Among his many honors was his service as Chairman of the Nobel Committee of Karolinska from 1990 to 1992.
-
-
- Nigel Richards, Ph.D.
-
- Dr. Richards is a professor in the department of biochemistry at the University of Florida.
-
-
- Lisette Hilton
Public Relations
- Ms. Hilton, President of Words Come Alive, is responsible for public relations for Ixion.
|
